IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 171 filers reported holding IVERIC BIO INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $17,583,776 | -73.0% | 821,288 | -77.3% | 0.36% | -76.1% |
Q3 2022 | $65,033,000 | -42.1% | 3,625,000 | -46.1% | 1.50% | -8.7% |
Q4 2021 | $112,402,000 | +3.0% | 6,722,624 | 0.0% | 1.64% | -0.3% |
Q3 2021 | $109,175,000 | +157.4% | 6,722,624 | 0.0% | 1.65% | +157.2% |
Q2 2021 | $42,420,000 | +2.1% | 6,722,624 | 0.0% | 0.64% | -1.4% |
Q1 2021 | $41,546,000 | -10.6% | 6,722,624 | 0.0% | 0.65% | -16.7% |
Q4 2020 | $46,453,000 | +23.6% | 6,722,624 | +0.9% | 0.78% | -13.9% |
Q3 2020 | $37,582,000 | +11.7% | 6,663,439 | +1.0% | 0.90% | -4.3% |
Q2 2020 | $33,642,000 | – | 6,596,536 | – | 0.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |